Children who have their tonsils and adenoids removed to alleviate obstructive sleep apnea (OSA) symptoms may not get the response they hope for, according to a Reuters report.
Medication for narcolepsy sufferers in Europe has taken a step forward with the recent recommendation that Xyrem, indicated in Europe for the treatment of cataplexy in adult patients with narcolepsy, be granted marketing authorization by the European Commission.
Respironics Inc achieved net sales for the second quarter totaling $288.7 million, up 12% over the $257.9 million achieved in the second quarter a year ago.
Keeping pace with the quickly growing and evolving field of sleep medicine, Sleep Holdings Inc, Dallas, is expanding its operations by entering into a letter of intent to acquire REM Sleep Diagnostics, located in Huntsville, Tex.
Caffeine has long been known to increase alertness and endurance, but a new study suggests that it also may help reduce the post-workout soreness that discourages some people from exercising.
Nearly 10% of sudden infant death syndrome (SIDS) victims have mutations or variations in genes associated with potentially lethal heart rhythms (arrhythmias), according to two newly published studies involving Vanderbilt researchers.
A developing insomnia medication is one step closer to hitting the market as phase II clinical trials of HY10275 demonstrated significant improvements in wake after sleep onset.
Beta blockers, a class of drugs commonly used to treat high blood pressure and other heart conditions, may help to control central sleep apnea in patients with congestive heart failure, according to research published in the January issue of CHEST.
A new study published in the January issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians, shows that patients with obstructive sleep apnea (OSA) are more likely than those without OSA to have a family history of premature death due to coronary artery disease (CAD).
Nearly 40% of US workers experience fatigue, a problem that carries billions of dollars in costs from lost productivity, according to a study in the January Journal of Occupational and Environmental Medicine.